- Home
- PRAX vs ASA Comparison
PRAX vs ASA Comparison
Compare PRAX & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- ASA
- Stock Information
- Founded
- PRAX 2015
- ASA 1958
- Country
- PRAX United States
- ASA United States
- Employees
- PRAX N/A
- ASA N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- ASA Precious Metals
- Sector
- PRAX Health Care
- ASA Industrials
- Exchange
- PRAX Nasdaq
- ASA Nasdaq
- Market Cap
- PRAX 599.7M
- ASA 549.0M
- IPO Year
- PRAX 2020
- ASA N/A
- Fundamental
- Price
- PRAX $38.55
- ASA $31.77
- Analyst Decision
- PRAX Strong Buy
- ASA
- Analyst Count
- PRAX 10
- ASA 0
- Target Price
- PRAX $116.50
- ASA N/A
- AVG Volume (30 Days)
- PRAX 320.6K
- ASA 55.7K
- Earning Date
- PRAX 05-02-2025
- ASA 06-10-2025
- Dividend Yield
- PRAX N/A
- ASA 0.16%
- EPS Growth
- PRAX N/A
- ASA N/A
- EPS
- PRAX N/A
- ASA 11.67
- Revenue
- PRAX $8,122,000.00
- ASA $3,557,386.00
- Revenue This Year
- PRAX N/A
- ASA N/A
- Revenue Next Year
- PRAX N/A
- ASA N/A
- P/E Ratio
- PRAX N/A
- ASA $2.71
- Revenue Growth
- PRAX 270.02
- ASA 45.39
- 52 Week Low
- PRAX $26.70
- ASA $16.97
- 52 Week High
- PRAX $91.83
- ASA $31.94
- Technical
- Relative Strength Index (RSI)
- PRAX 53.72
- ASA 62.35
- Support Level
- PRAX $35.21
- ASA $31.24
- Resistance Level
- PRAX $38.90
- ASA $31.93
- Average True Range (ATR)
- PRAX 2.09
- ASA 0.74
- MACD
- PRAX 0.07
- ASA 0.20
- Stochastic Oscillator
- PRAX 69.58
- ASA 95.89
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.